Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference39 articles.
1. Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer;Rahman;J. Clin. Oncol.,1997
2. Doubling epirubicin dose intensity (100 mg/m2 versus 50 mg/m2) in FEC regimen significantly increases response rates. An international randomised phase III study in metastatic breast cancer;Brufman;Ann. Oncol.,1997
3. Survival from first recurrence;Clark;J. Clin. Oncol.,1987
4. Diverse prognosis in metastatic breast cancer;Mick;Breast Cancer Treat. Res.,1989
5. Improved survival of patients with metastatic breast cancer receiving combination chemotherapy;Ross;Cancer,1985
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast Cancer;The Oncologist;2018-08-23
2. Prognostic Factors of Survival among Women with Metastatic Breast Cancer and Impact of Primary or Secondary Nature of Disease on Survival: A French Population-Based Study;The Breast Journal;2016-12-09
3. Bévacizumab et taxanes dans le traitement de première ligne du cancer du sein métastatique: survie globale et analyse de sous-groupes de l’étude ATHENA France;Bulletin du Cancer;2014-09
4. Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis;Breast Cancer Research and Treatment;2013-03-12
5. PPAR signaling pathway may be an important predictor of breast cancer response to neoadjuvant chemotherapy;Cancer Chemotherapy and Pharmacology;2012-08-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3